Brevan Howard Capital Management LP Geron Corp Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Geron Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 269,528 shares of GERN stock, worth $301,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
269,528
Previous 35,617
656.74%
Holding current value
$301,871
Previous $50,000
638.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GERN
# of Institutions
288Shares Held
502MCall Options Held
643KPut Options Held
276K-
Ra Capital Management, L.P. Boston, MA60.4MShares$67.6 Million1.42% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$52.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT41.1MShares$46 Million1.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.4MShares$38.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$30.5 Million5.93% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $423M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...